The drug developed by U.S. pharmaceutical giant Eli Lilly and Co. will be offered to patients experiencing ... Kisunla will ...

Eli Lilly has opened up a second market for its new Alzheimer's disease therapy Kisunla, after Japan followed the US in approving the drug. Kisunla (donanemab) is the second in a new generation of ...

and Japan, as well as Eli Lilly’s donanemab, which has been submitted for approval and is heading for an FDA advisory committee meeting. In addition, Roche and Lilly hope it could be deployed to ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

INDIANAPOLIS (AP) — INDIANAPOLIS (AP) — Eli Lilly and Co. (LLY) on Wednesday reported third-quarter earnings of $970.3 million. The Indianapolis-based company said it had profit of $1.07 per ...

If you’re on the fence about investing in Pfizer Inc or Eli Lilly And Co because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision. Read ...

If you’re on the fence about investing in Eli Lilly and Company or Novo Nordisk A/S because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...

Upgrade to begin using 40 years of financial statements and get so much more. Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all ...

Japan’s official development assistance (ODA) to China ended at the end of March after more than 40 years, bringing down the curtain on 3.6 trillion yen ($29 billion) of aid over the four decades.